Palatin Technologies, Inc. (PTN) Reports Q1 Loss of $0.04; Updates Bremelanotide Development
Tweet Send to a Friend
Palatin Technologies, Inc. (NYSE: PTN) reported Q1 EPS of ($0.04), versus ($0.17) reported last year. Revenue for the quarter came ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
